Press Release
Siloam Acquires Private General Hospital In Cirebon For Rp 130 Billion.
23 May 2017

Lippo Village, Tangerang, Indonesia
Tuesday, 23 May 2017

PT Siloam International Hospitals Tbk. (“Siloam”) today announces the acquisition of Rumah Sakit Umum
Putera Bahagia (“RSUPB”) in Cirebon, subject to final due diligence review results. The acquisition will be
made through 100% purchase by Siloam of RSUPB, in the amount of Rp 130 billion.

RSUPB is a 105 bed capacity hospital in Cirebon, West Java, a port city on the north coast of Java island
approximately 297 km east of Jakarta. The hospital operates in a 8,209 sqm four story building on 5,329
sqm land, both owned by RSUPB. The hospital, which has been registered to assist BPJS Kesehatan
patients, serves around 6,000 out-patient visits and around 340 in-patient admissions monthly. The 100
operational beds currently running at 63% occupancy rate generating IDR 63 bn annually. Going forward
Siloam plans to expand the bed capacity and to improve the facility and services by installing state-ofthe-
art medical equipment such as MRI and CT-Scan.

Ketut Budi Wijaya, President Director of Siloam stated, "Cirebon as the new growth centre in the east of
West Java has a very huge potential. There are two infrastructure megaprojects under construction within
a radius of 60 km from Cirebon, Kertajati International Airport and Patimban deep-sea port. For that
reason, we are very delighted to include Rumah Sakit Umum Putera Bahagia to our portfolio. This
acquisition will immediately contribute to the top line of the company. Importantly, this acquisition will
further strengthen Siloam’s presence in West Java being the 10th hospital located in the most populous
province in Indonesia with population of 47 million. This will help Siloam expand its portfolio of product
and service offerings to their constituents across not only Java island but also Indonesia.”

Siloam is a subsidiary of PT Lippo Karawaci Tbk (“LPKR”), the largest listed property company in Indonesia
by total assets and revenues, anchored by a large land bank and solid recurring income base. LPKR's
businesses comprise Residential/Township, Retail Malls, Hospitals, Hotels and Asset Management.

Siloam now operates 26 hospitals, 16 clinics in 19 cities throughout the country, and 5,300 beds
capacities supported by more than 2,400 specialists and general practitioners as well as over 8,600
nurses and support staff. It is also the first JCI accredited hospital in Indonesia and a repeat winner of
“Frost & Sullivan, Indonesia’s Healthcare Service Provider of the Year”. Siloam is listed on the
Indonesian Stock Exchange under the ticker name “SILO” and a market capitalization of Rp 15.3 trillion
or USD 1,154.5 million as of May 22, 2017.

For more information, please contact:

Anastasia Trivena Haliem
Investor Relations Manager
Siloam Hospitals Group

This press release has been prepared by PT Siloam International Hospitals Tbk (“Siloam”) and is circulated
for the purpose of general information only. It is not intended for any specific person or purpose and does
not constitute a recommendation regarding the securities of Siloam. No warranty (expressed or implied)
is made to the accuracy or completeness of the information. All opinions and estimations included in this
release constitute our judgment as of this date and are subject to change without prior notice. Siloam
disclaims any responsibility or liability whatsoever arising which may be brought against or suffered by
any person as a result of reliance upon the whole or any part of the contents of this press release and
neither Siloam nor any of its affiliated companies and their respective employees and agents accepts
liability for any errors, omissions, negligent or 3 otherwise, in this press release and any inaccuracy herein
or omission here from which might otherwise arise.

Forward-Looking Statements. Certain statements in this release are or may be forward- looking
statements. These statements typically contain words such as "will", "expects" and "anticipates" and
words of similar import. By their nature, forward looking statements involve a number of risks and
uncertainties that could cause actual events or results to differ materially from those described in this
release. Factors that could cause actual results to differ include, but are not limited to, economic, social
and political conditions in Indonesia; the state of the healthcare industry in Indonesia; prevailing market
conditions; increases in regulatory burdens in Indonesia, including environmental regulations and
compliance costs; fluctuations in foreign currency exchange rates; interest rate trends, cost of capital and
capital availability; the anticipated demand and selling prices for our healthcare and related capital
expenditures and investments; the cost of construction; availability of healthcare; competition from
other companies and venues; shifts in customer demands; changes in operation expenses, including
employee wages, benefits and training, governmental and public policy changes; our ability to be and
remain competitive; our financial condition, business strategy as well as the plans and objectives of our
management for future operations; generation of future receivables; and environmental compliance and
remediation. Should one or more of these uncertainties or risks, among others, materialize, actual results
may vary materially from those estimated, anticipated or projected. Specifically, but without limitation,
capital costs could increase, projects could be delayed and anticipated improvements in production,
capacity or performance might not be fully realized. Although we believe that the expectations of our
management as reflected by such forward-looking statements are reasonable based on information
currently available to us, no assurances can be given that such expectations will prove to have been
correct. You should not unduly rely on such statements. In any event, these statements speak only as of
the date hereof, and we undertake no obligation to update or revise any of them, whether as a result of
new information, future events or otherwise.